These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 29226832)

  • 1. The current treatment landscape of irritable bowel syndrome in adults in Hong Kong: consensus statements.
    Wu JC; Chan AO; Chan YW; Cheung GC; Cheung TK; Kwan AC; Leung VK; Mak AD; Sze WC; Wong R
    Hong Kong Med J; 2017 Dec; 23(6):641-7. PubMed ID: 29226832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of biologics for inflammatory bowel disease in Hong Kong: consensus statement.
    Leung WK; Ng SC; Chow DK; Lao WC; Leung VK; Li MK; Hui YT; Ng SS; Hui AJ; Lai ST; Lam JT; Poon JT; Chan AO; Yuen H; Wu JC; ;
    Hong Kong Med J; 2013 Feb; 19(1):61-8. PubMed ID: 23378357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus statements on adherence issues in schizophrenia for Hong Kong.
    Mak KY; Lo WT; Yeung WS; Wong M; Chung WS; Chui E; Tam KL; Hui LK; Mui J; Chan OW; Wong KL
    Asian J Psychiatr; 2014 Dec; 12():163-9. PubMed ID: 25440570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for the management of advanced and metastatic renal cell carcinoma: joint consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology.
    Poon DMC; Chan CK; Chan K; Chu WH; Kwong PWK; Lam W; Law KS; Lee EKC; Liu PL; Sze HCK; Wong JHM; Chan ESY
    Hong Kong Med J; 2022 Dec; 28(6):475-481. PubMed ID: 35815480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong Kong.
    Fong JK; Chan EL; Leung H; Chan I; Chang RS; Fong GC; Fung EL; Lui CH; Fung BB; Poon TL; Siu D; Wong HT; Yeung E; Yung AW; Zhu CX;
    Hong Kong Med J; 2017 Feb; 23(1):74-88. PubMed ID: 28184017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus statements on the clinical usage and characteristics of aripiprazole for Hong Kong.
    Wong MMC; Chung AKK; Yeung TMH; Wong DTW; Lee CK; Lai E; Chan GFY; Mak GKL; Wong JOY; Ng RMK; Tam KL; Mak KY
    Intern Med J; 2020 Sep; 50 Suppl 3():6-14. PubMed ID: 32985093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus statements on the management of clinically localized prostate cancer from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology.
    Ma WK; Poon DM; Chan CK; Chan TW; Cheung FY; Ho LY; Lee EK; Leung AK; Leung SY; So HS; Tam PC; Kwong PW
    BJU Int; 2019 Aug; 124(2):221-241. PubMed ID: 30653801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus statements on the management of metastatic prostate cancer from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology.
    Poon DM; Chan CK; Chan TW; Cheung FY; Kwong PW; Lee EK; Leung AK; Leung SY; Ma WK; So HS; Tam PC; Ho LY
    BJU Int; 2018 May; 121(5):703-715. PubMed ID: 29211320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidance on the clinical understanding and use of long-acting injectable antipsychotics in Schizophrenia: Hong Kong Consensus Statements.
    Wong MMC; Chung AKK; Yeung TMH; Wong DTW; Lee CK; Lai E; Chan GFY; Mak GKL; Wong JOY; Ng RMK; Mak KY
    CNS Neurosci Ther; 2021 Mar; 27 Suppl 1(Suppl 1):5-11. PubMed ID: 33555614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mexican consensus on irritable bowel syndrome.
    Carmona-Sánchez R; Icaza-Chávez ME; Bielsa-Fernández MV; Gómez-Escudero O; Bosques-Padilla F; Coss-Adame E; Esquivel-Ayanegui F; Flores-Rendón ÁR; González-Martínez MA; Huerta-Iga F; López-Colombo A; Méndez-Gutiérrez TH; Noble-Lugo A; Nogueira-de Rojas JR; Raña-Garibay RH; Remes-Troche JM; Roesch-Dietlen F; Schmulson MJ; Soto-Pérez JC; Tamayo JL; Uscanga LF; Valdovinos MÁ; Valerio-Ureña J; Zavala-Solares MR
    Rev Gastroenterol Mex; 2016; 81(3):149-67. PubMed ID: 26976238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hong Kong Urological Association-Hong Kong Society of Uro-Oncology consensus statements on the management of advanced prostate cancer-2019 Updates.
    Poon DM; Chan CK; Chan TW; Cheung FY; Ho LY; Kwong PW; Lee EK; Leung AK; Leung SY; So HS; Tam PC; Ma WK
    Asia Pac J Clin Oncol; 2021 Apr; 17 Suppl 3():12-26. PubMed ID: 33860645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2016 Consensus statement on prevention of atherosclerotic cardiovascular disease in the Hong Kong population.
    Cheung BM; Cheng CH; Lau CP; Wong CK; Ma RC; Chu DW; Ho DH; Lee KL; Tse HF; Wong AS; Yan BP; Yan VW
    Hong Kong Med J; 2017 Apr; 23(2):191-201. PubMed ID: 28387202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus statements on the clinical understanding and use of bupropion in Hong Kong.
    Lee WK; Au Yeung KL; Lam HB; Wong CK; Wong TC; Fu CK; Sham SK; Au MK; Lam TC; Ki-Yan Mak D
    CNS Neurosci Ther; 2021 Mar; 27 Suppl 1(Suppl 1):20-24. PubMed ID: 33555615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus statements on the clinical uses of pregabalin for Hong Kong.
    Kwong PP; Chan EY; Cheung EY; Fong SY; Nip W; Cheung HH; Yip IP; Chong KY; Pao RS; Tam KL; Tang MH; Chan SK; Mak KY
    Asia Pac Psychiatry; 2020 Sep; 12(3):e12403. PubMed ID: 32830438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus statements on the management of metastatic renal cell carcinoma from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology 2019.
    Poon DM; Chan CK; Chan K; Chu WH; Kwong PW; Lam W; Law KS; Lee EK; Liu PL; Sze HC; Wong JH; Chan ES
    Asia Pac J Clin Oncol; 2021 Apr; 17 Suppl 3():27-38. PubMed ID: 33860644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of overactive bladder: consensus statements from the Hong Kong Urological Association and the Hong Kong Geriatrics Society.
    Wong WKK; Kan RWM; Lam PS; Cheung PMH; Cheng EYL; Pun TCT; Tang MWS; Leung CLH; Woo SWS; Lo TK; Chu PSK; Chan TNH; Chiu PKF
    Hong Kong Med J; 2024 Aug; 30(4):310-319. PubMed ID: 39138142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noneffectiveness of electroacupuncture for comorbid generalized anxiety disorder and irritable bowel syndrome.
    Mak AD; Chung VCH; Yuen SY; Tse YK; Wong SYS; Ju Y; Hung SS; Leung KC; You JHS; Lui R; Wong SH; Leung ONW; Lam LCW; Lee S; Wu JCY
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1736-1742. PubMed ID: 30891824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive association between gastro-oesophageal reflux disease and irritable bowel syndrome in a Chinese population.
    Cheung TK; Lam KF; Hu WH; Lam CL; Wong WM; Hui WM; Lai KC; Lam SK; Wong BC
    Aliment Pharmacol Ther; 2007 May; 25(9):1099-104. PubMed ID: 17439511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian guidelines for the management of irritable bowel syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP).
    Barbara G; Cremon C; Bellini M; Corsetti M; Di Nardo G; Falangone F; Fuccio L; Galeazzi F; Iovino P; Sarnelli G; Savarino EV; Stanghellini V; Staiano A; Stasi C; Tosetti C; Turco R; Ubaldi E; Zagari RM; Zenzeri L; Marasco G
    Dig Liver Dis; 2023 Feb; 55(2):187-207. PubMed ID: 36517261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irritable bowel syndrome: the burden and unmet needs in Europe.
    Quigley EM; Bytzer P; Jones R; Mearin F
    Dig Liver Dis; 2006 Oct; 38(10):717-23. PubMed ID: 16807154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.